Web-Based Epilepsy Education Program for Adolescents and Parents

October 30, 2019 updated by: Şerife TUTAR GÜVEN, Suleyman Demirel University

Web-Based Epilepsy Education Program for Adolescents and Parents: A Randomized Controlled Trial

This study aims to develop a web-based epilepsy education program for adolescents with epilepsy and their parents and to evaluate the efficacy of eb-based epilepsy education program on health management.eb-based epilepsy education program has been proved to be a useful and reliable educational website for the development of knowledge, attitude, self-efficacy and e-health literacy of adolescents with epilepsy and their parents.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study aims to develop a web-based epilepsy education program for adolescents with epilepsy and their parents and to evaluate the efficacy of web-based epilepsy education program on health management.

This randomized controlled study was conducted with 69 adolescents with epilepsy aged between 9-18 and their parents (n=71) who were accepted to Pediatric Neurology Policlinic of Antalya Training and Research Hospital of Health Science University between November 2017 and April 2018. The study sample was divided into two groups as study (35 adolescents, 37 parents) and control (34 adolescents, 34 parents) groups using simple randomization method. The web-based epilepsy training program which was developed during the preparation stage of the study was evaluated by 13 experts using the Quality of Criteria for Consumer Health Information measurement instrument. The data collection materials (Seizure Self efficacy scale, E-Health literacy scale, Child Attitude Toward Illness Scale, Website Analysis and MeasureMent Inventory Scale) were administered by the researcher to the adolescents and parents in both groups before applying eb-based epilepsy education program. Following the administration of eb-based epilepsy education program to the initiative group, all participants were observed for three months. The data collection materials were reapplied to all the participants at the end of the third month. In addition, the adolescents and their parents in the study group were applied Website Analysis and Measurement Inventory measurement tool for the evaluation of usability of the site.

Study Type

Interventional

Enrollment (Actual)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Isparta, Turkey, 32200
        • Suleyman Demirel University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 50 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adolescents without mental disability,
  • Followed-up for at least six months with epilepsy diagnosis,
  • No chronic disease other than epilepsy,
  • No photosensitive epilepsy diagnosis,
  • Internet access and use, and parents of these adolescents with internet access and use - were included in the study.

Exclusion Criteria:

  • Adolescents and parents who do not use the Internet

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental
Web based education intervention
Web based education
No Intervention: No intervention
Normal polyclinics application

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Epilepsy Knowledge Test
Time Frame: 12 week
Epilepsy Knowledge test had applied pre-test and post-test. It consists of true (1), false (0) and I do not know (0) options. The minimum score to be taken from the scale is 0 and the maximum score is 25. The minimum score to be taken from the scale is 0 and the maximum score is 25. The increase in the total score indicates that the level of knowledge has increased.
12 week
Seizure Self Efficacy Scale
Time Frame: 12 week
Seizure Self Efficacy Scale had applied pre-test and post-test. The scale is a 5-point likert with 15 items. It has been interpreterd that the higher the total score, the higher is the self-efficacy level of the individual. The minimum score to be taken from the scale is 15 and the maximum score is 75.
12 week
Child Attitude Toward Ilness Scale
Time Frame: 12 week
Child Attitude Toward Ilness Scale had applied pre-test and post-test. The scale was a 5-point Likert type with 15 items. The minimum score to be taken from the scale is 15 and the maximum score is 75. 25. The minimum score to be taken from the scale is 0 and the maximum score is 25. The increase in the total score indicates that the child has positive attitude own illness.
12 week
e-Health Literacy Scale
Time Frame: 12 week
e-Health Literacy Scale had applied pre-test and post-test. The lowest score that can be obtained from the 5-point Likert scale is 8 and the highest score is 40. A high score from the scale indicates a high level of e-health literacy.
12 week
Website Analysis and MeasureMent Inventory
Time Frame: 12 week
Website Analysis and MeasureMent Inventory had applied both website under preparation and post test for control group.There are 5 dimensions that measure concepts like Attractiveness, Controllability, Efficiency, Helpfulness and Learnability. The total usability score is the weighted combination of expressions from each of the five sub-dimensions. The higher the scores obtained from the scale, the higher is the usability of the website and the more useful it is. The score obtained from the Website Analysis and MeasureMent Inventory is calculated in percentiles. the fact that each sub-dimension is above 50% means that its availability is high.
12 week
Quality of Criteria for Consumer Health Information
Time Frame: 12 week
Quality of Criteria for Consumer Health Information scale is to be used in the assessment of the content and quality of educational material. Quality of Criteria for Consumer Health Information consists of 15 key questions plus an overall quality rating. The low total score indicates a poor quality and the high score indicates a good quality. The minimum score to be taken from the scale is 15 and the maximum score is 75.
12 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2017

Primary Completion (Actual)

April 1, 2018

Study Completion (Actual)

June 28, 2018

Study Registration Dates

First Submitted

October 17, 2019

First Submitted That Met QC Criteria

October 27, 2019

First Posted (Actual)

October 30, 2019

Study Record Updates

Last Update Posted (Actual)

November 1, 2019

Last Update Submitted That Met QC Criteria

October 30, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • Suleyman Demirel University

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Research article

IPD Sharing Time Frame

2020-2021

IPD Sharing Access Criteria

Open access

IPD Sharing Supporting Information Type

  • Clinical Study Report (CSR)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Epilepsy

Clinical Trials on Web based education

3
Subscribe